Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion

Theradaptive Logo
Published on :

Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Medical Device designation for the use of OsteoAdapt SP in Anterior Lumbar Interbody Fusion. This is the third Breakthrough Designation for Theradaptive in spinal fusion, along with transforaminal interbody and posterolateral fusion, allowing it to address over 90% of lumbar spinal fusion procedures.

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion

Published on :

Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion Feb 15, 2022, 14:31 ET Theradaptive  FREDERICK, Md. and BOSTON, Feb. 15, 2022 /PRNewswire/ — Theradaptive, a privately held biopharmaceutical company pioneering a new class of [….]

Three Local Biotechs Focused on Improving Military Performance and Medical Care

Logos for ARMR Systems, Theradaptive, and Juxtopia overlayed on an image of soldiers' legs
Published on :

Biotech companies focused on developing biodefense products and measures are well known throughout the BioHealth Capital Region (BHCR). Companies like BioFactura, which is developing a smallpox therapeutic, and Emergent BioSolutions, which is advancing an anthrax vaccine, are two regional organizations BioBuzz has covered extensively. 

FDA Grants Theradaptive Breakthrough Medical Device Designation

Theradaptive Logo
Published on :

Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Medical Device designation to its Osteo-Adapt SP Spinal Fusion implant indicated for transforaminal lumbar interbody spinal fusion to treat degenerative disc disease, spondylolisthesis, or retrolisthesis.

Nine Veteran-Owned Life Science Companies to Know in the BioHealth Capital Region

Six BioHealth Capital Region Veteran-Owned Life Science Companies to Know
Published on :

On this Veteran’s Day 2020, we celebrate BHCR veteran-owned life science companies that you should keep an eye on as we head into 2021.

Industry Leaders Identify Key Growth Factors for Cell and Gene Therapy Market

Published on :

At Maryland Lifesciences’ 2020 Bio Innovation Conference, American Gene Technologies (AGT) took center stage. AGT was the virtual event’s diamond sponsor, AGT’s CEO and Founder Jeff Galvin kicked off the event with opening remarks and then hosted several panel discussions, including “Expanding Progress and Opportunities in Gene and Cell Therapy,” which was a highlight of the conference’s second day.